Peking University International Hospital
4 clinical trials · Sponsor
◉ Watch Peking University International Hospital
| Record | Firm | Date |
|---|---|---|
| Study of Sirolimus in IgG4-related Disease (NCT05746689) | Peking University International Hospital | 2023-03-01 |
| Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma (NCT05844813) | Peking University International Hospital | 2022-11-01 |
| Precision Bypass in Patients With Moyamoya Disease (NCT03516851) | Peking University International Hospital | 2018-08-01 |
| Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis (NCT04047576) | Peking University International Hospital | 2018-07-01 |
Track Peking University International Hospital automatically
Every clearance here is in the API, with alerts when new ones post.